Sign in
4

Changes in Ownership

GENELUX Corp Filed Acc 0001415889-25-012806

VP, Pharmaceutical Development sold 4,737 shares at $2.92 ($13,832)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cappello Joseph VP, Pharmaceutical Development 2025-05-12 Sale −4,737 $2.92 $13,832 52,266 D
Open-market sales · 4,737 sh · avg $2.92 · $13,832
Loading xslF345X05/form4-05132025_050531.xml…